IP Library Granted Patent US 7,049,110
Granted Patent B2
US 7,049,110 · App. 10/358,073 · Granted May 23, 2006

Inactivation of West Nile virus and malaria using photosensitizers

Assignee: Gambro, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,049,110
App. No.
10/358,073
Granted
May 23, 2006
Kind
B2
Abstract

Methods and apparatuses are provided for inactivation of microorganisms in fluids or on surfaces. Preferably the fluids contain blood or blood products and comprise biologically active proteins. Preferred methods include the steps of adding an effective, non-toxic amount of a photosensitizer to a fluid and exposing the fluid to photoradiation sufficient to activate the photosensitizer whereby microorganisms are inactivated.

Claims (20)

1. A method for treating a fluid to inactivate at least one type of parasite or virus that may be present therein, said fluid containing one or more components selected from the group consisting of: biologically active protein, blood, and blood constituents, without destroying the biological activity of such component, comprising:

(a) adding an inactivation effective, substantially non-toxic amount of an endogenous photosensitizer or endogenously-based derivative photosensitizer other than a porphyrin to the fluid; and

(b) exposing the fluid of step (a) to photoradiation sufficient to activate the photosensitizer, whereby at least one parasite or virus in the fluid is inactivated.

2. The method of claim 1 , wherein the parasite comprises P. falciparum.

3. The method of claim 1 , wherein the fluid comprises red blood cells and the photoradiation has a wavelength of about 447 nm.

4. The method of claim 1 , further comprising adding air to the fluid and photosensitizer before exposing the fluid to photoradiation.

5. The method of claim 1 , wherein the photosensitizer is a nucleic-acid-targeted non-toxic, photoactivatable compound which does not produce toxic photolytic breakdown products.

6. The method of claim 1 , wherein the photosensitizer is endogenous.

7. The method of claim 6 , wherein the photosensitizer is 7,8-dimethyl-10-ribityl isoalloxazine.

8. The method of claim 1 , wherein the virus comprises West Nile virus.

9. The method of claim 1 , wherein the photoradiation comprises one or more wavelengths in the visible spectrum.

10. The method of claim 1 , wherein the photoradiation comprises one or more wavelengths in the ultraviolet spectrum.

11. The method of claim 1 , wherein said fluid of step (a) is exposed to a source of photoradiation at a depth selected to ensure penetration of the photoradiation through the fluid and inactivation of the parasite or virus.

12. The method of claim 1 , wherein the fluid comprises blood constituents.

13. The method of claim 1 , wherein the fluid is whole blood.

14. The method of claim 1 , wherein the fluid is a separated blood product.

15. The method of claim 1 , wherein an endogenous photosensitizer is added to anticoagulant and said anticoagulant is added to the fluid.

16. The method of claim 1 , wherein the photosensitizer is capable of inactivating viruses or parasites at a pH of about 7.4.

17. The method of claim 1 , wherein the photosensitizer is capable of inactivating viruses or parasites in the presence of plasma, cells or blood components.

18. The method of claim 1 , wherein the photosensitizer inactivates at least one type of parasite or virus present in human blood.

Assignments (9)
CHANGE OF NAME Recorded Feb 16, 2012
From: CARIDIANBCT BIOTECHNOLOGIES, LLC.
To: TERUMO BCT BIOTECHNOLOGIES, LLC
Reel/Frame 027715/0552 →
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
To: GAMBRO, INC.
Reel/Frame 026209/0914 →
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
To: CARIDIANBCT BIOTECHNOLOGIES, LLC
Reel/Frame 026192/0547 →
CHANGE OF NAME Recorded Jul 28, 2008
From: NAVIGANT BIOTECHNOLOGIES, LLC
To: CARIDIANBCT BIOTECHNOLOGIES, LLC.
Reel/Frame 021301/0099 →
CONVERSION Recorded Apr 27, 2007
From: NAVIGANT BIOTECHNOLOGIES, INC.
To: NAVIGANT BIOTECHNOLOGIES, LLC
Reel/Frame 019224/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2007
From: GAMBRO, INC.
To: NAVIGANT BIOTECHNOLOGIES, INC.
Reel/Frame 018787/0354 →
SECURITY AGREEMENT Recorded Nov 29, 2006
From: GAMBRO, INC.
To: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
Reel/Frame 018552/0717 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2005
From: GAMBRO BCT, INC.
To: GAMBRO, INC.
Reel/Frame 016255/0034 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2003
From: REDDY, HEATHER; GOODRICH, RAYMOND P.
To: GAMBRO BCT, INC.
Reel/Frame 013522/0075 →
Continuity (5)
Continuation In Part 0958614700 · Jun 2, 2000
Continuation In Part 0935718800 · Jul 20, 1999
Continuation In Part 0911966600 · Jul 21, 1998
Provisional Application 6035316200 · Feb 1, 2002
Related Publication 20040018997A1 · Jan 29, 2004